AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2004 JUL 5 - (NewsRx.com & NewsRx.net) -- CardioTech International, Inc., (CTE) announced that its wholly-owned DermaPhylyx International, Inc., subsidiary has been accepted as a Medicare supplier of Durable Medical Equipment, Orthotics, Prosthetics and Supplier (DMEPOS), also known as a Medicare Participating Provider (MPP).
Under the status, Medicare patients who order HydroMed or AlgiMed can receive wound dressings at no out-pocket expenses to them, since DermaPhylyx will now be eligible for Medicare reimbursement. Medicare patients may now order their wound dressing needs by telephone, email or in person at DermaPhylyx International, Inc., 229 Andover St. Wilmington, MA 01887.
Michael Szycher, CEO and Chairman of CardioTech International, stated: "We are very pleased to announce that we have been awarded the coveted Medicare Participating Provider Status. I believe this will contribute significantly in advancing the sales and distribution of our wound dressings."
DermaPhylyx is marketing two advanced, moist wound healing products: HydroMed and AlgiMed. HydroMed is a non-adhering, moisture donating hydrogel sheet containing 90% water and 10% hydrophilic polymer. It is intended for use on lightly exudating wounds. HydroMed is intended for use in the management of chronic wounds.
AlgiMed is a wound dressing intended for use on moderate to heavily exudating wounds. Alginate is a natural polymer derived from seaweed, which promotes healing by absorbing excess fluid, controlling bleeding and forming a gel, which keeps ...
Source: HighBeam Research, DermaPhylyx awarded "Medicare Participating Provider" status.